Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ajinomoto Co. Inc.
DescriptionOrally administered enzyme to reduce excess levels of urate
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia/gout
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today